TATX-28

N/A

Report date: 2023/08/02 17:09:56

Base Information

Drug NameTATX-28
Drug Alias NameTATX-28
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCD276 antigen modulators
TargetsCD276 antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmniAb Inc
China Registration ClassN/A

Develop Information

Active CompaniesTalem Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A